An expert body under India’s apex drug regulator has recommended against granting approval to Pfizer’s Covid vaccine under emergency circumstances, prompting the American drug giant to withdraw its request.
Official records show the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) made the recommendation to the Drug Controller General of India (DCGI) due to concerns over Serious Adverse Events (SAEs).
